Skip to main content
. 2020 Feb 15;11(4):918–927. doi: 10.1111/1759-7714.13340

Figure 2.

Figure 2

(a) The DFS analysis for 750 patients with NSCLC (P < 0.001). (b) The OS analysis for 750 patients with NSCLC (P < 0.001). Inline graphic≤12.65, Inline graphic>12.65. PDW, platelet distribution width; DFS, disease‐free survival; OS, overall survival; NSCLC, non‐small cell lung cancer.